Peter Bell mainly focuses on Virology, Transduction, Genetic enhancement, Virus and Transgene. The concepts of his Virology study are interwoven with issues in Vector, Nucleic acid, Gene expression and Immunology. His work deals with themes such as Gene delivery, Adeno-associated virus, Mutant and Capsid, which intersect with Transduction.
His Genetic enhancement research includes elements of Liver disease, Internal medicine and Endocrinology. His work on Neutralizing antibody as part of general Virus research is often related to Germinal center, thus linking different fields of science. His Transgene research incorporates elements of Retina, Immune system and Cell biology.
The scientist’s investigation covers issues in Genetic enhancement, Virology, Immunology, Transgene and Virus. His research in Genetic enhancement intersects with topics in Vector, Pharmacology, Molecular biology and Pathology. His work carried out in the field of Virology brings together such families of science as Viral vector, Adeno-associated virus and Immunity.
His study focuses on the intersection of Immunology and fields such as Mucopolysaccharidosis type I with connections in the field of Iduronidase. He interconnects Gene expression, T cell, Immune system, microRNA and Transduction in the investigation of issues within Transgene. His research integrates issues of Genetic transfer and Antigen in his study of Virus.
Peter Bell mostly deals with Genetic enhancement, Transgene, Adeno-associated virus, Virus and Pharmacology. He combines subjects such as Mutation, Vector, Cerebrospinal fluid and Molecular biology with his study of Genetic enhancement. His Transgene study incorporates themes from Immune system, Immunology, Transduction and Cell biology.
His Immunology study combines topics from a wide range of disciplines, such as Lysosomal storage disease and Mucopolysaccharidosis type I. His biological study spans a wide range of topics, including Iduronidase and Factor IX. His Virus research includes themes of Toxicity, Immunosuppression, Vectors in gene therapy and Locus.
Peter Bell mainly investigates Virus, Genetic enhancement, Immunology, Transgene and Adeno-associated virus. His studies deal with areas such as Stem cell, Cell biology, Transduction and Locus as well as Virus. Peter Bell has included themes like Virology, Spinal muscular atrophy, Acute toxicity, Capsid and Genetically modified mouse in his Transduction study.
Peter Bell works mostly in the field of Genetic enhancement, limiting it down to topics relating to Cisterna magna and, in certain cases, Mucopolysaccharidosis VII, as a part of the same area of interest. His Transgene research is multidisciplinary, incorporating elements of Blood–brain barrier, Phenotype, LDL receptor, Vectors in gene therapy and Pharmacology. His work carried out in the field of Adeno-associated virus brings together such families of science as Iduronidase, Motor neuron and Mucopolysaccharidosis type I.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation
Kasirajan Ayyanathan;Mark S. Lechner;Peter Bell;Gerd G. Maul.
Genes & Development (2003)
A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice
Yang Yang;Yang Yang;Lili Wang;Peter Bell;Deirdre McMenamin.
Nature Biotechnology (2016)
Review: properties and assembly mechanisms of ND10, PML bodies, or PODs.
Gerd G. Maul;Dmitri Negorev;Peter Bell;Alexander M. Ishov.
Journal of Structural Biology (2000)
Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN
Christian Hinderer;Nathan Katz;Elizabeth Lynne Buza;Cecilia Dyer.
Human Gene Therapy (2018)
Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype.
Rita Sarkar;Renee Tetreault;Guangping Gao;Lili Wang.
Reassessment of the Roles of Integrase and the Central DNA Flap in Human Immunodeficiency Virus Type 1 Nuclear Import
Jeffrey D. Dvorin;Peter Bell;Gerd G. Maul;Masahiro Yamashita.
Journal of Virology (2002)
Dosage Thresholds for AAV2 and AAV8 Photoreceptor Gene Therapy in Monkey
Luk H. Vandenberghe;Peter Bell;Albert M. Maguire;Cassia N. Cearley.
Science Translational Medicine (2011)
The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice
Christie L. Bell;Luk H. Vandenberghe;Peter Bell;Maria P. Limberis.
Journal of Clinical Investigation (2011)
Biology of AAV Serotype Vectors in Liver-Directed Gene Transfer to Nonhuman Primates
Guangping Gao;You Lu;Roberto Calcedo;Rebecca L. Grant.
Molecular Therapy (2006)
CpG-depleted adeno-associated virus vectors evade immune detection
Susan M. Faust;Peter Bell;Benjamin J. Cutler;Scott N. Ashley.
Journal of Clinical Investigation (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: